Recombinant subcutaneous human beta-Defensin 2 (hBD2) ameliorates experimental colitis in different in vivo models D. Mailander-Sanchez, S. Kjaerulf,K. Sidelmann Brinch,B. Andersen,E. F. Stange,N. Malek, P. Nordkild,J. WehkampJournal of Crohns & Colitis（2017）引用 3|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
